Summary:

  House Bill171 (HB171) relates to pharmacies by modifying the Pharmacy Act to provide for custodial care facilities acquiring and possessing controlled substances for withdrawal management. 

Legislation Overview:

 House Bill171 (HB171) adds a new Section to the Pharmacy Act allows for medically monitored withdrawal management that is under the supervision of a consulting pharmacist and has nursing staff on-site twenty-four hours per day, three hundred sixty-five days per year, and may acquire, stock, maintain and have in the facility's possession dangerous drugs, including controlled substances to be used for withdrawal management purposes.
Also, "controlled substance" means a drug, substance or immediate precursor enumerated in Schedules III and V of the Controlled Substances Act.
 

Amendments:

 Amended February 13,2025 in HHHC
HHHCa/HB171The House Health and Human Service Committee amendment reads as follows: 
1. On page 2, line 2, before the period, insert ", in accordance with board rules". 
2. On page 2, between lines 5 and 6, insert: 
"SECTION 2. EFFECTIVE DATE.--The effective date of the provisions of this act is January 1, 2026.".,